Literature DB >> 15048867

Viral appropriation of apoptotic and NF-kappaB signaling pathways.

Andrew G Bowie1, Jun Zhan, William L Marshall.   

Abstract

Viruses utilize a variety of strategies to evade the host immune response and replicate in the cells they infect. The comparatively large genomes of the Orthopoxviruses and gammaherpesviruses encode several immunomodulatory proteins that are homologous to component of the innate immune system of host cells, which are reviewed here. However, the viral mechanisms used to survive host responses are quite distinct between these two virus families. Poxviruses undergo continuous lytic replication in the host cytoplasm while expressing many genes that inhibit innate immune responses. In contrast, herpesviruses persist in a latent state during much of their lifecycle while expressing only a limited number of relatively non-immunogenic viral proteins, thereby avoiding the adaptive immune response. Poxviruses suppress, whereas latent gammaherpesviruses activate, signaling by NF-kappaB, yet both viruses target similar host signaling pathways to suppress the apoptotic response. Here, modulation of apoptotic and NF-kappaB signal transduction pathways are examined as examples of common pathways appropriated in contrasting ways by herpesviruses and poxviruses. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048867     DOI: 10.1002/jcb.20026

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  19 in total

1.  The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions.

Authors:  Zhi Sun; Zhenhai Chen; Steven R Lawson; Ying Fang
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 2.  Bats: important reservoir hosts of emerging viruses.

Authors:  Charles H Calisher; James E Childs; Hume E Field; Kathryn V Holmes; Tony Schountz
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 3.  Viral subversion mechanisms in chronic kidney disease pathogenesis.

Authors:  Leslie A Bruggeman
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

4.  Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis.

Authors:  Bibhuti B Mishra; Pramod K Mishra; Judy M Teale
Journal:  J Neuroimmunol       Date:  2006-09-29       Impact factor: 3.478

5.  Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7.

Authors:  Wolfgang Peti; Margaret A Johnson; Torsten Herrmann; Benjamin W Neuman; Michael J Buchmeier; Mike Nelson; Jeremiah Joseph; Rebecca Page; Raymond C Stevens; Peter Kuhn; Kurt Wüthrich
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 6.  The TRAIL to viral pathogenesis: the good, the bad and the ugly.

Authors:  Nathan Cummins; Andrew Badley
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

7.  Toll-like receptor 8 polymorphism and coronary artery disease.

Authors:  Zhong Chen; Genshan Ma; Qi Qian; Yuyu Yao; Yi Feng; Chengchun Tang
Journal:  Mol Biol Rep       Date:  2008-11-05       Impact factor: 2.316

8.  Understanding PRRSV infection in porcine lung based on genome-wide transcriptome response identified by deep sequencing.

Authors:  Shuqi Xiao; Jianyu Jia; Delin Mo; Qiwei Wang; Limei Qin; Zuyong He; Xiao Zhao; Yuankai Huang; Anning Li; Jingwei Yu; Yuna Niu; Xiaohong Liu; Yaosheng Chen
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

9.  Co-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013.

Authors:  Masmudur M Rahman; Mohamed R Mohamed; Manbok Kim; Sherin Smallwood; Grant McFadden
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

10.  Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.

Authors:  Robert Valentine; Christopher W Dawson; Chunfang Hu; Khilan M Shah; Thomas J Owen; Kathryn L Date; Sonia P Maia; Jianyong Shao; John R Arrand; Lawrence S Young; John D O'Neil
Journal:  Mol Cancer       Date:  2010-01-05       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.